Xiangping Deng

575 total citations
26 papers, 465 citations indexed

About

Xiangping Deng is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Xiangping Deng has authored 26 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Organic Chemistry. Recurrent topics in Xiangping Deng's work include Cancer, Hypoxia, and Metabolism (11 papers), Synthesis and biological activity (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Xiangping Deng is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Synthesis and biological activity (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Xiangping Deng collaborates with scholars based in China, Czechia and United States. Xiangping Deng's co-authors include Guotao Tang, Zhe Wang, Xing Zheng, Wenhu Zhou, Jinsong Ding, Xiaoyong Lei, Zhizhong Xie, Yanming Chen, Juan Liu and Xing Zheng and has published in prestigious journals such as International Journal of Pharmaceutics, RSC Advances and Cancer Letters.

In The Last Decade

Xiangping Deng

23 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangping Deng China 11 183 178 143 113 72 26 465
Vanminh Le China 14 226 1.2× 112 0.6× 159 1.1× 55 0.5× 93 1.3× 17 583
Dujuan Zhao China 9 190 1.0× 282 1.6× 218 1.5× 64 0.6× 23 0.3× 11 509
Maryam Ghaffari Iran 8 428 2.3× 201 1.1× 151 1.1× 83 0.7× 39 0.5× 14 771
Debasmita Dutta United States 13 246 1.3× 98 0.6× 67 0.5× 50 0.4× 38 0.5× 29 478
Dasharath Chaudhari India 16 230 1.3× 230 1.3× 143 1.0× 68 0.6× 40 0.6× 28 577
Venkateswararao Eeda South Korea 13 223 1.2× 213 1.2× 145 1.0× 208 1.8× 25 0.3× 38 705
Sivaneswari Srinivasan India 8 122 0.7× 155 0.9× 143 1.0× 111 1.0× 17 0.2× 26 496
Mengjie Rui China 16 301 1.6× 210 1.2× 267 1.9× 30 0.3× 57 0.8× 31 701
Haishi Qiao China 17 266 1.5× 178 1.0× 278 1.9× 41 0.4× 68 0.9× 35 752
Shaomei Yang China 11 227 1.2× 187 1.1× 107 0.7× 38 0.3× 32 0.4× 22 484

Countries citing papers authored by Xiangping Deng

Since Specialization
Citations

This map shows the geographic impact of Xiangping Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangping Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangping Deng more than expected).

Fields of papers citing papers by Xiangping Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangping Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangping Deng. The network helps show where Xiangping Deng may publish in the future.

Co-authorship network of co-authors of Xiangping Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangping Deng. A scholar is included among the top collaborators of Xiangping Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangping Deng. Xiangping Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qianyu, Xiangping Deng, Zhizhong Xie, et al.. (2025). Discovery of novel chalcone derivatives containing benzimidazole possessing anti-tumor potential in vitro and in vivo. Biomedicine & Pharmacotherapy. 194. 118912–118912.
2.
Wang, Zhe, et al.. (2025). Research progress of flavonoids targeting estrogen receptor in the treatment of breast cancer. Bioorganic & Medicinal Chemistry. 120. 118106–118106.
3.
Zhou, Yuguang, Meijing Liu, Na Lü, et al.. (2025). Advances in the design and application of glycolysis-related nanodelivery systems for anti-tumor. Colloids and Surfaces B Biointerfaces. 254. 114844–114844. 2 indexed citations
4.
Tang, Ming‐Jer, Yiyang Li, Yonghong Peng, et al.. (2025). Reversing the Warburg effect: Discovery of potent pyruvate dehydrogenase kinase inhibitors for inhibiting tumor growth. Bioorganic Chemistry. 167. 109224–109224.
5.
He, Xianghuo, Zhe Wang, Zhizhong Xie, et al.. (2025). Discovery of novel flavonoid derivatives targeting VEGFR2 and tubulin with potent anticancer efficacy. Bioorganic Chemistry. 163. 108713–108713. 2 indexed citations
6.
Lu, Guozhong, Yin Zhao, Xianghuo He, et al.. (2025). Intranuclear TCA and mitochondrial overload: The nascent sprout of tumors metabolism. Cancer Letters. 613. 217527–217527. 2 indexed citations
7.
Zhang, Jing, Jia Yu, Meijing Liu, et al.. (2024). Small-molecule modulators of tumor immune microenvironment. Bioorganic Chemistry. 145. 107251–107251. 6 indexed citations
8.
Li, Yiyang, Zhizhong Xie, Xiaoyong Lei, et al.. (2024). Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities. Bioorganic Chemistry. 144. 107160–107160. 11 indexed citations
9.
Wu, Guang, Zhizhong Xie, Xiaoyong Lei, et al.. (2024). pH regulators and their inhibitors in tumor microenvironment. European Journal of Medicinal Chemistry. 267. 116170–116170. 26 indexed citations
10.
Deng, Xiangping, Yang Zou, Xiaoyong Lei, et al.. (2020). Synthesis and biological evaluation of novel 5,6,7-trimethoxy flavonoid salicylate derivatives as potential anti-tumor agents. Bioorganic Chemistry. 96. 103652–103652. 14 indexed citations
11.
Deng, Xiangping, et al.. (2020). FB-15 inhibits MGC-803 cells growth by regulating energy metabolism. Chemico-Biological Interactions. 327. 109186–109186. 5 indexed citations
12.
He, Dongxiu, Xiangping Deng, Juan Liu, et al.. (2019). Design, synthesis and biological evaluation of tryptamine salicylic acid derivatives as potential antitumor agents. MedChemComm. 10(4). 573–583. 11 indexed citations
13.
Liu, Juan, Honglin Huang, Xiangping Deng, et al.. (2019). Design, synthesis and broad-spectrum Bcr-Abl inhibitory activity of novel thiazolamide–benzamide derivatives. RSC Advances. 9(4). 2092–2101. 5 indexed citations
14.
Deng, Xiangping, et al.. (2019). Anticancer Activity of Natural Flavonoids: Inhibition of HIF-1α Signaling Pathway. Current Organic Chemistry. 23(26). 2945–2959. 11 indexed citations
15.
Wang, Zhe, Juan Liu, Xiangping Deng, et al.. (2018). A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy. Colloids and Surfaces B Biointerfaces. 173. 346–355. 31 indexed citations
16.
Deng, Xiangping, Zhongli Li, Juan Liu, et al.. (2018). FS-7 inhibits MGC-803 cells growth in vitro and in vivo via down-regulating glycolysis. Biomedicine & Pharmacotherapy. 109. 1659–1669. 10 indexed citations
17.
Deng, Xiangping, Zhe Wang, Xuan Thang Cao, et al.. (2018). Preparation of scutellarin loaded TPGS polymeric micelles and evaluation of its pharmacokinetics and pharmacodynamics effects in rats. Acta Poloniae Pharmaceutica - Drug Research. 75(6). 1305–1312. 1 indexed citations
18.
Wang, Zhe, Xiangping Deng, Juan Liu, et al.. (2017). Design, synthesis and biological evaluation of chrysin benzimidazole derivatives as potential anticancer agents. Natural Product Research. 32(24). 2900–2909. 36 indexed citations
19.
Wang, Zhe, Xiangping Deng, Jinsong Ding, et al.. (2017). Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: A review. International Journal of Pharmaceutics. 535(1-2). 253–260. 222 indexed citations
20.
Xiang, Lei, Ying Liu, Xiangping Deng, et al.. (2016). Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery. Journal of Pharmacy and Pharmacology. 68(6). 751–761. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vanminh Le Breakdown of academic impact, for papers by Dujuan Zhao Breakdown of academic impact, for papers by Maryam Ghaffari Breakdown of academic impact, for papers by Debasmita Dutta Breakdown of academic impact, for papers by Dasharath Chaudhari Breakdown of academic impact, for papers by Venkateswararao Eeda Breakdown of academic impact, for papers by Sivaneswari Srinivasan Breakdown of academic impact, for papers by Mengjie Rui Breakdown of academic impact, for papers by Haishi Qiao Breakdown of academic impact, for papers by Shaomei Yang
Rankless by CCL
2026